Evidence map›Paper›PMID 25076408›Full record

ArticlePloS one2014

Extracellular HCV-core protein induces an immature regulatory phenotype in NK cells: implications for outcome of acute infection.

Lucy Golden-Mason, Young S Hahn, Michael Strong, Linling Cheng, Hugo R Rosen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Biomarkers in Detection of Hepatitis C Virus Infection.Pathogens (Basel, Switzerland) · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Control of HCV Infection by Natural Killer Cells and Macrophages.Cold Spring Harbor perspectives in medicine · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lucy Golden-MasonDivision of Gastroenterology & Hepatology & Hepatitis C Center, University of Colorado, Aurora, Colorado, United States of America.
Young S HahnBeirne Carter Center for Immunology Research, Department of Microbiology & Pathology, University of Virginia, Charlottesville, Virginia, United States of America.
Michael StrongBioinformatics, Department of Medicine, University of Colorado, Aurora, Colorado, United States of America.
Linling ChengDivision of Gastroenterology & Hepatology & Hepatitis C Center, University of Colorado, Aurora, Colorado, United States of America.
Hugo R RosenDivision of Gastroenterology & Hepatology & Hepatitis C Center, University of Colorado, Aurora, Colorado, United States of America; Denver Veterans Affairs (VA), Denver, Colorado, United States of America.
University of Colorado Anschutz Medical Campus · USCarter Center · US

Funding

Suppression of HCV-specific CD4+ T Cells by Core ProteinU19AI066328 · NIAID · UNIVERSITY OF COLORADO DENVER · PI ROSEN, HUGO RAMON · 2005 to 2014
$6.8M
Role of HCV in aberrant APC activation/functionR01AI098126 · NIAID · UNIVERSITY OF VIRGINIA · PI HAHN, YOUNG S. · 2012 to 2016
$1.9M
NIAID NIH HHS R01 AI098126NIAID NIH HHS U19 AI066328
6 · The paper itself

Abstract

backgroundHepatitis C viral (HCV) proteins, including core, demonstrate immuno-modulatory properties; however, the effect of extracellular core on natural killer (NK) cells has not previously been investigated.

aimsTo characterise NKs in acute HCV infection over time, and, to examine the effect of exogenous HCV-core protein on NK cell phenotype and function.

methodsAcute HCV patients (n = 22), including 10 subjects who spontaneously recovered, were prospectively studied. Flow-cytometry was used to measure natural cytotoxicity and to phenotype NKs directly ex vivo and after culture with HCV-core protein. Microarray analysis was used to identify pathways involved in the NK cell response to exogenous HCV-core.

resultsDirect ex vivo analysis demonstrated an increased frequency of immature/regulatory CD56bright NKs early in acute HCV infection per se which normalized with viral clearance. Natural cytotoxicity was reduced and did not recover after viral clearance. There was a statistically significant correlation between the frequency of CD56bright NKs and circulating serum levels of HCV core protein. In vitro culture of purified CD56bright NK cells with HCV-core protein in the presence of IL-15 maintained a significant proportion of NKs in the CD56bright state. The in vitro effect of core closely correlates with NK characteristics measured directly ex vivo in acute HCV infection. Pathway analysis suggests that HCV-core protein attenuates NK interferon type I responses.

conclusionsOur data suggest that HCV-core protein alters NK cell maturation and may influence the outcome of acute infection.

Indexed as

AdultCD56 AntigenCell CountCytotoxicity, ImmunologicExtracellular SpaceFemaleGene Expression ProfilingGene Regulatory NetworksHepacivirusHepatitis CHumansImmunophenotypingKiller Cells, NaturalLymphocyte SubsetsMaleMiddle AgedCD56 AntigenViral Core Proteins

Identifiers

PMID25076408
PMCPMC4116173
OpenAlexW2040787282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.